The FDA has authorised two synthetic formulations of THC for dealing with specific conditions: nabilone and dronabinol.THC targets receptors in a fashion less selective than endocannabinoid molecules, and its pharmacodynamic tolerance could Restrict maximal consequences of particular medication when boosting the drug's therapeutic window.Although w… Read More